MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in just a couple of days, plus support MedWorm at the same time.
Thursday, May 26, 2011
Selection of Patients With Malignant Pleural Mesothelioma for Extrapleural Pneumonectomy
Introduction: Malignant pleural mesothelioma (MPM) is known to have an aggressive natural history with a life expectancy of less than 12 months. In recent decades, a number of studies have shown encouraging results for extrapleural pneumonectomy (EPP), especially as part of a multi-modality therapy. However, EPP can be associated with prohibitive morbidity and mortality rates, and appropriate patient selection is vital to ensure optimal surgical outcome. The present systematic review aims to identify the significant prognostic factors for patients who undergo EPP in order to improve the patient selection process. (Source: Heart, Lung and Circulation)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment